PRESS RELEASE: Fifth International Pharma Congress Features Keynote Address by Mark Pieth, Professor of Criminal Law, Basel University, Chairman, Working Group on Bribery in International Business Transactions, Organization for Economic Co-operation and Development (OECD)
  • Sponsored by the Pharmaceutical Compliance Forum
  • Featuring Tracks on EU, CEE and MEA
  • May 3 - 5, 2011
  • Polat Renaissance Istanbul Hotel
  • Istanbul, Turkey
  • www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-684-4549
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com

WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JANUARY 5, 2011: The International Pharmaceutical Regulatory and Compliance Congress, www.InternationalPharmaCongress.com, May 3 - 5, 2011 will be held at the Polat Renaissance Istanbul Hotel in Istanbul, Turkey. The International Pharma Congress is sponsored by the Pharmaceutical Compliance Forum.

FEATURING KEYNOTE ADDRESS BY:

Mark Pieth, PhD
Professor of Criminal Law, Basel University, Chairman, Working Group on Bribery in International Business Transactions, Organization for Economic Co-operation and Development (OECD) Member, Swiss Federal Gaming Commission, Board Chairman, Basel Institute on Governance, Basel, Switzerland
Professor Peith's background includes:
  • Former Head of Section - Economic and Organized Crime, Swiss Federal Office of Justice (Ministry of Justice and Police)
  • Former Member of the Financial Action Task Force on Money Laundering (FATF)
  • Former Member of the Chemical Action Task Force on Precursor Chemicals
  • Former Chair, intergovernmental expert group charged by the United Nations with determining the extent of the illicit traffic in drugs
  • Former Member, UN Secretary General to the Independent Inquiry Committee into the Iraq Oil-for-Food Programme
  • Former Member, Integrity Advisory Board of The World Bank Group


CONGRESS CO CHAIRS

Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN, USA

Dominique Laymand, Esq.
Executive Director Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France

Roeland Van Aelst
Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium

FEATURING PHARMA COMPLIANCE TRACKS ON
  • European Union Compliance Update
  • Central and Eastern Europe Compliance Update
  • Middle East and Africa Compliance Update
  • Global Compliance Audits and Monitoring
  • FCPA and Global Anticorruption
  • Global Transparency, Discourse and Aggregate Spend
  • Global Compliance Case Studies

FEATURING
KEYNOTE SPEAKERS

Philippa Foster Back, OBE
Director, Institute of Business Ethics, Chairman, UK Antarctic Heritage Trust, Past President, Association of Corporate Treasurers, London, UK

Bulent Becan
Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey

Joe Henein
President and Chief Executive Officer, NewBridge Pharmaceuticals, Former Regional Managing Director, Middle East & North Africa, Wyeth Pharmaceuticals, Dubai, United Arab Emirates




Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain




Marie-Claire Pickaert
Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Mark Pieth, PhD
Professor of Criminal Law, Basel University, Chairman, Working Group on Bribery in International Business Transactions, Organization for Economic Co-operation and Development (OECD), Member, Swiss Federal Gaming Commission, Board Chairman, Basel Institute on Governance, Basel, Switzerland
SPECIAL SESSIONS ON EUROPEAN UNION COMPLIANCE ISSUES BY:

Gabor Danielfy
Senior Director, Health Care Compliance and Privacy EMEA, Johnson & Johnson, Issy-les-Moulineaux, France

Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc., Mannheim, Germany



Gerard Geneen
Vice President, Compliance Officer, Pharma Europe, GlaxoSmithKline, Brentford, Middlesex, UK

Gary F. Giampetruzzi, Esq.
Deputy Compliance Officer, International Investigations and Programs, Pfizer Inc., New York, NY, USA



Barbara R. Giddings, RN, MHA, CHC
Global Commercial Compliance, Biogen Idec, Weston, MA

Artur Nagapetyan
Country Compliance Officer, Novartis Pharma LLC, Moscow, Russian Federation

Jeffrey Rosenbaum
Global Head, Ethics and Compliance, Novartis Oncology, Florham Park, NJ, USA

Paul B. Woods, BPharm, MA, MRPharmS
Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK
SPECIAL SESSIONS ON MIDDLE EAST/AFRICA COMPLIANCE ISSUES BY:

Nabil Daoud
Managing Director, MENA, Eli Lilly and Company, Chair, MEA LAWG Ethics Review Board, Beirut, Lebanon

Nidal Fakhoury
Regional Managing Director - Middle East, MSD, Merck, Chairman, PhRMAG, Dubai, United Arab Emirates

Sameh Farag
Regional Compliance Director, MEA, Merck, Dubai, United Arab Emirates

Liz MacGillivray
Head of Compliance AMAC Region (Asia Pacific, Middle East & African Countries), Novartis, Jumeirah Village, United Arab Emirates
AND PROMINENT COMPLIANCE CONSULTANTS AND LEGAL ADVISORS

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, Department of Justice, Washington, DC, USA

Jeremy Cole, Esq.
Partner, Hogan Lovells, London, UK

Gary DiBianco, Esq.
Partner, Skadden Arps LLP, Former Trial Attorney, Criminal Division, Former Special Assistant US Attorney, Eastern District of Virginia, US Department of Justice, London, UK

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, London, UK

Patricia A. Etzold, CPA
Partner, PricewaterhouseCoopers LLP, New York, NY, USA

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former First Assistant US Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC, USA

Ryan Murphy
Director, PricewaterhouseCoopers LLP, Chicago, IL, USA

SanDee Priser
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Frankfurt am Main, Germany

Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA

Michael Roberts, Esq.
Senior Associate, Hogan Lovells, London, UK

Guillaume Roussel
Vice President, Compliance Solutions EMEA, Cegedim, Paris, France

Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division of the United States Department of Justice, Washington, DC, USA

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland

Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
2011 INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN, USA (Co chair)

Dominique Laymand, Esq.
Executive Director Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France (Co chair)

Roeland Van Aelst
Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium (Co chair)

Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France

Ann Beasley Bacon
Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland

Wayne Baker
Sr. Vice President, Advanced Health Media LLC, Bridgewater, NJ, USA

Karie Jo Barwind, Esq.
Area Director Business Practices, Western Europe, Abbott Laboratories, Rungis Cedex, France

Bulent Becan
Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Washington, DC, USA

Gabor Danielfy
Senior Director, Health Care Compliance and Privacy EMEA, Johnson & Johnson, Issy-les-Moulineaux, France

Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc., Mannheim, Germany
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

Sameh Farag
Regional Compliance Director, MEA, Merck, Dubai, United Arab Emirates

Gerard Geneen
Vice President, Compliance Officer, Pharma Europe, GlaxoSmithKline, Brentford, Middlesex, UK

Gary F. Giampetruzzi, Esq.
Assistant General Counsel and Chief of Government Investigations, Pfizer, Inc., New York, NY, USA

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Maxine Nogard
Senior Director, Global Corporate Compliance, Biogen Idec Inc., Weston, MA, USA

Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA

Jeffrey Rosenbaum
Global Head, Ethics & Compliance, Novartis Oncology, Florham Park, NJ, USA

Guillaume Roussel
Vice President, Compliance Solutions EMEA, Cegedim, Paris, France

Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division of the United States Department of Justice, Washington, DC, USA

Paul B. Woods, BPharm, MA, MRPharmS
Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK

Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium

CONGRESS REGISTRATION

For Congress registration information, visit www.InternationalPharmaCongress.com/registration.php, email registration@hcconferences.com, or call 800-503-8171.


CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information contact Joni Lipson, Exhibit Manager, 215-952-0866 phone, 215-952-0664 fax, joni.lipson@lipsonllc.com.




EARLY BIRD REGISTRATION
Click Here to register by Friday, January 28, 2011 and save €200.

SPEAKER PRESENTATION PROPOSALS
Speaker/Presentation Proposals for the International Pharma Congress May Be Submitted Through Our Online Form
- Click Here -

SPONSORED BY:


The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.



GRANTORS:
DIAMOND

GOLD

SILVER

BRONZE










PAST INTERNATIONAL PHARMA CONGRESSES


2007 - Brussels, Belgium


2008 - Paris, France


2009 - Rome, Italy


2010 - Berlin, Germany

SAVE THE DATE

FIRST ASIAN INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS

September 2011
Singapore
www.AsianPharmaCongress.com

TWELFTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS

Sponsored by Pharmaceutical Compliance Forum
November 2 - 4, 2011
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
FOLLOW INTERNATIONAL PHARMA CONGRESS ON